You are here

Novomedix, LLC

Company Information
Address
7966 Arjons Dr Ste D
San Diego, CA 92126-6361
United States


https://www.novomedix.com

Information

DUNS: 620623764

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. Novel small molecules for protection against doxorubicin cardiotoxicity in TNBC

    Amount: $375,001.00

    Project SummaryThe overall goal of this program is to discover and develop a first in class small molecule that provides cardioprotective and beneficial anti tumor effects with standard of care chemot ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  2. Novel antifibrotic small molecules for the treatment of heart failure

    Amount: $300,000.00

    DESCRIPTION provided by applicant The overall goal for this project is the development of safer more effective drugs for the treatment of heart failure Heart disease is the number one cause of de ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  3. The optimization of compounds that selectively inhibit protein synthesis for the

    Amount: $2,000,000.00

    DESCRIPTION (provided by applicant): The goal of this program is to complete the appropriate preclinical studies to support an IND for a first-in- class small molecule therapeutic for triple negative ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  4. Development of novel small molecule drugs for the treatment of high risk B-ALL

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): The goal of this program is to develop and ultimately commercialize small molecule drugs for the treatment of high risk pediatric B-cell acute lymphoblastic leukem ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  5. Optimization of compounds that selectively inhibit protein synthesis for the trea

    Amount: $300,236.00

    DESCRIPTION (provided by applicant): The goal of this program is to develop and ultimately commercialize small molecule drugs that inhibit cap- dependent translation initiation for the treatment of tr ...

    SBIRPhase I2010Department of Health and Human Services National Institutes of Health
  6. Discovery and Development of Compounds to Enhance b-cell Number and Function

    Amount: $516,697.00

    DESCRIPTION (provided by applicant): The goal of this program is to develop and ultimately commercialize small molecule drugs that induce (-cell replication and/or differentiation for the treatment ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government